NCT00667641
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +67 more
- Locations
-
- Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States
Clinical trial condition
Bronchial Neoplasms
Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.
5,246 public trials
1,181 recruiting studies
Bronchial Neoplasms trial results
NCT00193336
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
NCT00317200
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- Highlands Oncology Group Springdale, Arkansas, United States
- Medical & Surgical Specialists, LLC Galesburg, Illinois, United States
- Cancer Care Center of Southern Indiana Bloomington, Indiana, United States
- Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States
Completed
A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)
NCT00403403
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
Not specified
Completed
Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC)
NCT01024062
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
NCT00391274
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guangzhou, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China
NCT00528619
- Conditions
- Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +12 more
- Locations
-
- Pfizer Investigational Site Aurora, Colorado, United States
- Pfizer Investigational Site Ottawa, Ontario, Canada
- Pfizer Investigational Site Montreal, Quebec, Canada
NCT00010023
- Conditions
- Adenocarcinoma, Appendiceal Neoplasms, Bile Duct Diseases, +70 more
- Locations
-
- NYU Cancer Institute at New York University Medical Center New York, United States
Completed
Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer
NCT00737867
- Conditions
- Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
- Locations
-
- Øystein Fløtten Bergen, Norway
- Sverre Fluge Haugesund, Norway
- Heidi Rolke Kristiansand, Norway
- Tore Amundsen Trondheim, Norway
NCT00540241
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bad Homburg, Germany